NEUROTECH INTERNATIONAL
Neurotech,is a medical device and solutions company incorporated in Australia, Operating through its wholly-Owned, malta-based subsidiary, AAT Reaserch limited.
NEUROTECH INTERNATIONAL
Industry:
Life Science Medical Medical Device
Founded:
2016-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.neurotechinternational.com
Total Employee:
11+
Status:
Active
Contact:
+61 (0)8 9321 5922
Email Addresses:
[email protected]
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Nginx Sitelinks Search Box
Similar Organizations
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Vamstar
GenAI-powered Global B2B Healthcare Marketplace
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.neurotechinternational.com
- Host name: 45.76.113.197.vultrusercontent.com
- IP address: 45.76.113.197
- Location: Alexandria Australia
- Latitude: -33.9256
- Longitude: 151.1906
- Timezone: Australia/Sydney
- Postal: 2015
More informations about "Neurotech International"
Neurotech International • ASX:NTI
Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders with a broad-spectrum …See details»
Board and Management • Neurotech International
More than 20 years’ experience in trading, investment banking & providing corporate advice. Specialises in providing corporate advice & capital raising services to emerging companies seeking business development opportunities …See details»
Biopharmaceutical Trials • Neurotech International
Neurotech International is conducting clinical studies to assess the neuro-protective, anti-inflammatory and neuro-modulatory activities of our proprietary NTI/Dolce cannabis strains.See details»
Neurotech International Ltd | LinkedIn
Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders.See details»
Neurotech International Limited - AnnualReports.com
Neurotech International Limited is focused on facilitating the development and commercialisation of solutions for the screening and treatment of symptoms associated with neurological …See details»
Executive Change - Neurotech International Limited (ASX:NTI)
Sep 1, 2022 · For more information about Neurotech please visit http://www.neurotechinternational.com. 1 ASX Announcement 16 August 2022 – Consultant …See details»
Neurotech Receives HREC/TGA Approval for Phase II/III ASD Trial …
Nov 17, 2022 · For more information about Neurotech please visit http://www.neurotechinternational.com. About NTI164 NTI164 is a proprietary drug formulation …See details»
Neurotech to Launch Phase II Clinical Trial in Rett Syndrome For ...
Ndomised, double-blind, placebo-controlled clinical trial in ASD during Q4 CY2022. Neurotech plans to conduct additional Phase I/II trials in Paediatric Autoimmune Neuropsychiatric …See details»
Neurotech Granted FDA Pre-IND Meeting for NTI164 in Autism …
Jan 19, 2023 · biopharmaceutical development company focused predominately on paediatric neurological disorders. Neurotech has completed a Phase I/II clinical trial in Autism Spectrum …See details»
NEUROTECH INTERNATIONAL LIMITED ANNUAL REPORT - 30 …
Website: www.neurotechinternational.com Email: [email protected] AUDITORS BDO Audit (WA) Pty Ltd 38 Station Street SUBIACO WA 6008 SHARE REGISTRY Automic …See details»
Factsheet: Neurotech International
O-modulation and neuro-regulation. Grown in Australia under strict horticultural conditions that ensure its integrity, NTI164 has a high level of cannabidiolic acid (CBDA) and an assortment of …See details»
NTI Formalises Strategic Partnership with Fenix Innovation
Jun 3, 2024 · NTI Formalises Strategic Partnership with Fenix Innovation - Neurotech International Limited (ASX:NTI) - Listcorp. Melbourne, Australia. neurological disorders. The …See details»
Neurotech International Ltd - LinkedIn
Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders.See details»
Neurotech International Company Description - Stock Analysis
Sep 30, 2024 · Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices …See details»
Rett Syndrome Patients to Receive NTI164 for 52 Weeks
Mar 13, 2024 · For more information about Neurotech please visit http://www.neurotechinternational.com. About NTI164 NTI164 is a proprietary drug formulation …See details»
Neurotech International Limited (ASX: NTI) - Intelligent Investor
May 31, 2024 · Neurotech International Limited (NTI), an ASX-listed company, is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological …See details»
Neurotech Files for US Orphan Drug Designation in Rett …
H a broad-spectrum oral cannabinoid drug therapy called NTI164. Neurotech has completed a Phase II/III randomised, double-blind, placebo-controlled clinical trial in Autism Spectrum …See details»
Research - Neurotech International
Sep 19, 2022 · This field is for validation purposes and should be left unchanged. Copyright © 2024 Neurotech International • Site by White Noise CommunicationsSee details»
NTI.AX - | Stock Price & Latest News | Reuters
Nov 19, 2024 · Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on …See details»
ASX Announcements - Neurotech International
For further historical ASX Announcements please visit asx.com.au.See details»